Skip to main content

Desoxypipradrol Facts

Stimulant; Substituted piperidine; Norepinephrine-dopamine reuptake inhibitor

Description

Desoxypipradrol — also known as 2-DPMP, sold as "Ivory Wave" — is a synthetic stimulant of the piperidine class. It blocks dopamine and norepinephrine clearance in the brain, causing forceful, sustained stimulation.

Subjective effects include wakefulness, appetite suppression, mood elevation, cognitive drive, agitation, and paranoia. The experience is defined by its relentlessness — early clarity gives way to a grinding stimulation that resists sleep for one to three days.

Desoxypipradrol carries high abuse liability and severe acute toxicity — muscle breakdown occurred in 96% of one emergency case series,[1] and deaths have been reported. The extraordinary duration amplifies every risk: a single dose sustains cardiovascular overload for days, and no antidote exists.[2]

Dose and durationby route · individual sensitivity varies

Oral(mg)
Threshold< 0.25 mgLight1 – 2 mgCommon2 – 6 mgStrong6 – 8 mgHeavy8+ mg

Starts in 1 – 4 hoursLasts 16 – 72 hours

Body and dependence

Acute toxicity
High
Chronic toxicity
Moderate
Physical dependence
Moderate
Psychological dependence
High
Withdrawal
Moderate
Compulsive redosing
High

Tolerance

Builds
Moderate
Fully resets after
10.5 days
Carries over to
cocaine; methylphenidate; amphetamine

Effectslikely at a common dose

Body
Stimulation; Wakefulness; Insomnia; Appetite suppression; Restlessness; Dry mouth; Pupil dilation; +22 possible, including Vasoconstriction, Muscle tension, Heart rate perception changes
Thinking
none likely · 18 possible, including Compulsive redosing urge, Cognitive dysphoria, Decision impairment
Feeling
none likely · 8 possible, including Anxiety, Anhedonia, Depression
Self
none likely · 7 possible, including Craving, Ego inflation, Compulsive repetitive behavior

Who shouldn't take it

Absolute
Cardiovascular disease; Psychotic spectrum disorders; Pregnancy and lactation; MAOI use
Relative
Seizure disorders; Renal impairment

Combinations61 recorded

Lethal (1)
Tramadol
Dangerous (29)
Amphetamines; Ephedrine, Pseudoephedrine; Local anesthetics; MAOIs; MDMA, Amphetamines; NRIs; Stimulants; Alpha-2 adrenergic receptor antagonist; Anticholinergics; Antipsychotics; Caffeine; Clonidine, Guanfacine; Dopamine agonists; GHB, Baclofen; GHB, GBL; Ibogaine; Ketamine, DXM, PCP; Lithium; MDMA, MDA; NSAIDs; Opioids; Poppers (Alkyl nitrites); Poppers, Nitrates; Psychedelics; and 5 more, see full page
Caution (27)
See full page: psychedex.org/substances/desoxypipradrol
Not graded (4)
Not listed never means safe.

Seek help immediately if

  • Chest pain; racing, pounding, or irregular heartbeat
  • Very high body temperature; heavy sweating; hot, flushed skin
  • Severe agitation, paranoia, panic, or confusion
  • Severe headache; muscle rigidity or twitching
  • Seizures
  • Signs of stroke — face drooping, one-sided weakness, slurred speech
  • Difficulty breathing; collapse or unconsciousness

What to do

  1. Call emergency services for chest pain, overheating, seizure, or unresponsiveness
  2. Move them to a cool, quiet place and reduce stimulation
  3. Cool the body — remove excess clothing, apply cool damp cloths, fan them
  4. Keep them calm; reassure — panic worsens the cardiovascular strain
  5. If seizing, protect from injury (don't restrain); recovery position afterward
  6. Monitor breathing and be ready to give rescue breaths / CPR

Most stimulant overdoses settle with cooling, a calm environment, and time. The medical danger is hyperthermia, cardiac events (arrhythmia, heart attack, stroke), and seizures — get help immediately if any appear.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Murray DB, Potts S, Haxton C, Jackson G, Sandilands EA, Ramsey J, Puchnarewicz M, Holt DW, Johnston A, Bateman DN, Dear JW (2012) 'Ivory wave' toxicity in recreational drug users; integration of clinical and poisons information services to manage legal high poisoning — Clinical Toxicology doi:10.3109/15563650.2011.647992
  2. [2]
    ^Corkery JM, Elliott S, Schifano F, Corazza O, Ghodse AH (2012) 2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review — Progress in Neuro-Psychopharmacology & Biological Psychiatry doi:10.1016/j.pnpbp.2012.05.021
Print version
Report an issue